Study of the Relationship Between Serum Adiponectin and Clinical Prognosis in Patients Undergoing Cardiac Surgery

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01393535

Enrollment

800

Registered

2011-07-13

Start date

2011-07-31

Completion date

2012-08-31

Last updated

2011-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Surgery

Keywords

Adiponectin, Prognosis, Cardiac Surgery

Brief summary

The purpose of this study is to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.

Detailed description

Adiponectin, an adipose tissue derived protein, is an abundant protein hormone regulatory of numerous metabolic processes. Since its discovery, adiponectin has garnered considerable attention for its role in cardiovascular pathology. It has been shown to be a predictor of cardiovascular events in both the general population and patients undergoing cardiac surgery. In this study,we are planning to investigate the relationship between serum adiponectin and clinical prognosis in patients undergoing cardiac surgery.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Patients who had underwent cardiac surgery from July 2011 to August 2012 in xijing hospital.

Exclusion criteria

* Nothing particular.

Countries

China

Contacts

Primary ContactChunhu Gu, MD

guchunhu@fmmu.edu.cn

Outcome results